Imagine a computer that doesn't use electricity and silicon, but instead uses liquid chemicals to think. It works like a tiny artificial brain on a chip, where chemical reactions process information just like our own neurons do. This allows the device to 'speak' the same language as living cells and bodies.
Traditional AI is energy-intensive and cannot interact directly with biological systems. There is a need for computing that 'speaks' the molecular language of the body for advanced medical implants.
A microfluidic chip system that uses chemical reaction networks to perform computing tasks, integrated with automated data extraction tools like FT-IR and UV-Vis spectroscopy.
If you are a medical device manufacturer dealing with the need for real-time drug delivery—this project developed chemical computing on microfluidic chips that can synthesize drug molecules in situ. This allows for personalized medicine tailored to the patient's immediate molecular environment.
If you are a biosensor developer dealing with high energy costs for AI processing—this project developed a chemical reservoir computing system that processes information in a 'metabolic' way. This creates a more sustainable alternative to traditional electronic AI.
If you are a brain-machine interface startup dealing with the difficulty of interfacing electronics with biological tissue—this project developed a system that mimics the brain's chemical reactions. This enables devices that can communicate directly with the brain's molecular signals.
Based on available project data, specific pricing for the technology is not provided, though the project utilizes low-cost monitoring techniques like UV-Vis spectroscopy.
The project focuses on scalable reservoir computing using microfluidic flow reactors, though specific industrial volume capacities are not listed.
Based on available project data, there is no specific mention of patents or licensing terms; the project is currently in the research and development phase.
The system integrates with AI through algorithmic cheminformatics and machine learning tools to monitor and interpret output molecular patterns.
The project period runs from 2022-04-01 to 2026-03-31, suggesting the technology is still in the development stage.
The project is led by a university with a strong academic lean (4 universities, 1 research center), but maintains a 29% industry ratio with 2 industrial partners. This balance suggests a transition from fundamental science to applied technology, supported by a mix of 7 partners across 5 countries, including a specialized SME for dissemination.
Contact Universidad Autonoma de Madrid
Contact us to connect with the CORENET consortium for licensing discussions.
